Current treatment of age-related macular degeneration

Simple item page
dc.coverageDOI: 10.1016/j.rmclc.2023.08.005
dc.creatorDíaz, Juan Ignacio Verdaguer
dc.date2023
dc.date.accessioned05-01-2026 18:09
dc.date.available05-01-2026 18:09
dc.description<p>Age related macular degeneration (AMD) is the most common cause of irreversible vision loss in people over 65 years of age. Its origin is multifactorial, involving aging as well as various genetic and environmental factors such as smoking, obesity and diet. It mainly affects the outer retina (retinal pigment epithelium and photoreceptors) in the macular area. It is classified into “non-neovascular” and “neovascular”. The “non-neovascular” form is characterized by the presence of soft drusen, which can evolve towards progressive macular atrophy and a gradual loss of visual acuity. In the “neovascular” form, abnormal blood vessels develop, usually growing from the choroid, into the subretinal or subepithelial pigment space with exudation of fluid and blood with sudden loss of vision. This leads to fibrosis and irreversible damage to the outer retina. This article analyzes the classification and current state of treatment of age-related macular degeneration.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/18fdf160-1a7c-42b1-8f62-6c1b38620819
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.34 (2023) date: 2023-09-01 nr.5 p.335-343
dc.subjectChoroidal Neovascularization
dc.subjectGeographic Atrophy
dc.subjectMacular Degeneration
dc.subjectSoft Drusen
dc.subjectSDG 3 - Good Health and Well-being
dc.titleCurrent treatment of age-related macular degenerationeng
dc.titleTratamiento actual de la degeneración macular relacionada con la edadspa
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
Pure-CRIS